Karen Schneck, PharmD

PK/PD/Pharmacometrics
Eli Lilly and Company

Poster(s):

• (T-030) PK/PD/PD Models Enable Quantitative Insights into the Exposure-Efficacy Relationships of Tirzepatide for Treatment of Obstructive Sleep Apnea
  Tuesday, October 21, 2025

  7:00 AM - 1:45 PM MDT